Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence.
Defreyne, J
Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. [electronic resource] - Andrology 05 2018 - 446-454 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
2047-2927
10.1111/andr.12485 doi
Adult
Androgen Antagonists--therapeutic use
Cohort Studies
Cyproterone Acetate--therapeutic use
Estradiol--therapeutic use
Europe
Female
Hematocrit
Humans
Male
Prospective Studies
Reference Values
Gender-Affirming Procedures
Testosterone--therapeutic use
Transgender Persons
Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. [electronic resource] - Andrology 05 2018 - 446-454 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
2047-2927
10.1111/andr.12485 doi
Adult
Androgen Antagonists--therapeutic use
Cohort Studies
Cyproterone Acetate--therapeutic use
Estradiol--therapeutic use
Europe
Female
Hematocrit
Humans
Male
Prospective Studies
Reference Values
Gender-Affirming Procedures
Testosterone--therapeutic use
Transgender Persons